ArticleOncotarget2017
Combining vasculature disrupting agent and Toll-like receptor 7/8 agonist for cancer therapy.
Anushree Seth et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this papercites it
ArticleOncotarget2017
Anushree Seth et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.